Live feed
Filing
SC 13G
SC 13G0001213900-20-002392·Trillium Therapeutics Inc.
Schedule 13G ownership disclosure
TRILLIUM THERAPEUTICS INC COM NEW
Security class unavailable · CUSIP: 89620X506
Event date: 2020-01-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 820,940
- Percent of class
- 1.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-002392
- Form type
- SC 13G
- Filer
- Trillium Therapeutics Inc.
- CIK
- CIK 1616212
- Filed
- Feb 03, 2020
- Reporting period
- Jan 27, 2020
- Description
- Schedule 13G beneficial ownership